UHPLC–MS/MS Quantification of Human Cytosolic Aldehyde Oxidase: Heat‐Assisted In‐Solution Protein Denaturation and Digestion
Rapid Communications in Mass Spectrometry · 2026
DOI: 10.1002/rcm.70058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2026. Verfasst von Shiyan Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Aldehyde Oxidase, Tandem Mass Spectrometry, Cytosol. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Medical Research Council - Singapore, Natural Sciences and Engineering Research Council of Canada, Ministry of Education-Singapore.
Abstract (Originalsprache)
Rationale
The quality of protein denaturation and digestion is critical in determining the performance of a UHPLC–MS/MS method in absolute protein quantification. Previous UHPLC–MS/MS methods on human aldehyde oxidase (AOX1) protein provided little or no methodological information on protein denaturation and digestion. Therefore, we developed and optimized a sample preparation method for the UHPLC–MS/MS quantification of human cytosolic AOX1.
Methods
Various reagents and conditions in protein denaturation (urea, Rapigest, temperature, heating time, and acetonitrile) and digestion (incubation time) were evaluated. A UHPLC–MS/MS method was developed and validated for quantifying the surrogate peptide 446 VFFGEGDGIIR 456 for AOX1 and its stable‐isotope‐labelled internal standard.
Results
Surrogate peptide yield was improved by our optimized conditions for AOX1 protein denaturation (heating at 80°C for 15 min together with reduction by DL‐dithiothreitol, acetonitrile not added during trypsin digestion) and protein digestion (4 h). A solvent composition of 40% water‐10% acetonitrile‐50% ammonium bicarbonate buffer enhanced peptide solubility and assay linearity and sensitivity. An AOX1‐negative cytosol was an appropriate matrix blank for cellular samples. The UPHLC–MS/MS assay validation metrics were within acceptable FDA guidelines, highlighted by peptide stability during sample preparation, a shorter run time (11.5 min), greater sensitivity (7.5 fmol), broader linearity range (7.5–10 000 fmol), allowing for the low femtomole quantification of human cytosolic AOX1.
Conclusions
Our novel methodological advances, as highlighted by a high temperature, in‐solution protein denaturation protocol and optimal digestion time, solvent composition, and matrix blank, enabled the femtomole quantification of AOX1 protein using a validated UHPLC–MS/MS method with better assay performance than previous methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.
- College of Pharmacy, Faculty of Health, Dalhousie University, Halifax, Canada.
- Department of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Canada.
ORCID-Profile: Aik Jiang Lau
Förderung
- National Medical Research Council - Singapore
- Natural Sciences and Engineering Research Council of Canada
- Ministry of Education-Singapore
Zitieren
APA
Chen, S., & Lau, A. J. (2026). UHPLC–MS/MS Quantification of Human Cytosolic Aldehyde Oxidase: Heat‐Assisted In‐Solution Protein Denaturation and Digestion. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.70058
Vancouver
Chen S, Lau AJ. UHPLC–MS/MS Quantification of Human Cytosolic Aldehyde Oxidase: Heat‐Assisted In‐Solution Protein Denaturation and Digestion. Rapid Communications in Mass Spectrometry. 2026. doi:10.1002/rcm.70058
BibTeX
@article{Chen2026,
author = {Chen, Shiyan and Lau, Aik Jiang},
title = {UHPLC–MS/MS Quantification of Human Cytosolic Aldehyde Oxidase: Heat‐Assisted In‐Solution Protein Denaturation and Digestion},
journal = {Rapid Communications in Mass Spectrometry},
year = {2026},
doi = {10.1002/rcm.70058}
}
EUVIMED